• Hummingbird Resources 2nd quarter blog comment

    July 19, 2018 | Posted by

    Hummingbird Resources is becoming a successful commercial gold producer. This was demonstrated by Q2 2018 production results today which have really shown that the Yanfolila Gold Mine in Mali is delivering results. Gold production numbers from Yanfolila for the 3 months ended 30 June 2018 cover the first dull quarter of commercial production since the […]

  • Zak Mir interviews Joao Andrade, CEO of Widecells

    July 16, 2018 | Posted by

    Zak Mir interviews Joao Andrade, CEO of Widecells. Click the play button to listen to the audio. https://zakmir.files.wordpress.com/2018/07/joao-widecells_2018-07-16_11-10-58.mp3 Key points discussed: Why are stem cells significant and how is Widecells taking advantage? How competitive is the market for stem cell heath care insurance? In which countries do you see the best growth opportunities? Do you […]

  • Game changing news for Gaming Realms – shares remain dramatically undervalued

    June 28, 2018 | Posted by

    By Richard Gill, CFA Gaming Realms (GMR) was one of the top performers on the markets on Wednesday, the shares closing the day up by 20% at 12p after the company announced the proposed sale of its UK Real Money Casino brands and business. Conditional upon shareholder approval, the deal will see a 70% stake sold in […]

  • Mayan Energy update 27 Jun 18

    June 27, 2018 | Posted by

    By Dr Michael Green Following the placing of £850,000 (gross) at Mayan Energy on Monday this week (in which we participated), it looks as though investors are about to see an acceleration of the progress in the new Mayan Energy story. After 18 months of sorting out the mess that was Mayan, Managing Director Eddie […]

  • Statement to Valirx shareholders

    June 24, 2018 | Posted by

    Following a constructive meeting with Dr Satu Vainikka and other company members last Friday at Valirx in which the 2 primary elements of our open letter were re-iterated: namely management alignment with regards to their Valirx stock holdings and the corporate capital financing approach pursued by the company in recent years, I believe that going forward […]

Loading More